Liposomal gp100 vaccine combined with CpG ODN sensitizes established B16F10 melanoma tumors to anti PD-1 therapy

OBJECTIVE(S): Program death 1 (PD-1)/ program death-ligand 1 (PD-L1) pathways, as the main inhibitory checkpoints, induce immunosuppression in the tumor microenvironment (TME). Despite the importance of inhibitor checkpoint receptor (ICR) blockers, their outcomes have been limited by the low immune...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Iran J Basic Med Sci
Prif Awduron: Yazdani, Mona, Hatamipour, Mahdi, Alani, Behrang, Nikzad, Hossein, Mohamadian Roshan, Nema, Verdi, Javad, Jaafari, Mahmoud Reza, Noureddini, Mahdi, Badiee, Ali
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Mashhad University of Medical Sciences 2020
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7478250/
https://ncbi.nlm.nih.gov/pubmed/32952954
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22038/ijbms.2020.46654.10762
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg